33358 Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 731–TA–1546–1549 

(Final)] 

Thermal Paper From Germany, Japan, 

Korea, and Spain; Notice of Correction 

Concerning Scheduling of Record 

Closing and Final Comments 

AGENCY: United States International 

Trade Commission. 

ACTION: Correction of notice. 

SUMMARY: Correction is made to the 

October 20, 2021 date of record closing, 

and the October 22, 2021 deadline for 

filing final comments, in the Written 

Submissions section of the notice which 

was published on June 9, 2021 (86 FR 

30627). The correct deadline dates are 

as follows: The record closing is October 

19, 2021; and deadline for final 

comments is October 21, 2021. 

By order of the Commission. 

Issued: June 14, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–13345 Filed 6–23–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Bureau of Alcohol, Tobacco, Firearms 

and Explosives 

[OMB Number 1140–0003] 

Agency Information Collection 

Activities; Proposed eCollection of 

eComments Requested; Revision of a 

Currently Approved Collection; Report 

of Multiple Sale or Other Disposition of 

Pistols and Revolvers—ATF Form 

3310.4 

AGENCY: Bureau of Alcohol, Tobacco, 

Firearms and Explosives, Department of 

Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Bureau of Alcohol, 

Tobacco, Firearms and Explosives 

(ATF), Department of Justice (DOJ), will 

submit the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection 

(IC) OMB 1140–0003 (Report of 

Multiple Sale or Other Disposition of 

Pistols and Revolvers—ATF Form 

3310.4) is being revised due to an 

increase in the total respondents, 

responses, and burden hours. A minor 

change to update the firearms 

description columns was made to the 

form. The proposed IC is also being 

published to obtain comments from the 

public and affected agencies. 

DATES: Comments are encouraged and 

will be accepted for 60 days until 

August 23, 2021. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

regarding the estimated public burden 

or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions, or 

additional information, please contact: 

Neil Troppman, Law Enforcement 

Support Branch, National Tracing 

Center Division, either by mail at 244 

Needy Road, Martinsburg, WV 25405, 

by email at neil.troppman@atf.gov, or by 

telephone at 304–260–3643. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection 

(check justification or form 83): 

Revision of a currently approved 

collection. 

2. The Title of the Form/Collection: 

Report of Multiple Sale or Other 

Disposition of Pistols and Revolvers. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

Form number (if applicable): ATF 

Form 3310.4. 

Component: Bureau of Alcohol, 

Tobacco, Firearms and Explosives, U.S. 

Department of Justice. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Primary: Business or other for-profit. 

Other (if applicable): Federal 

Government and State, Local, or Tribal 

Government. 

Abstract: The Report of Multiple Sale 

or Other Disposition of Pistols and 

Revolvers—ATF Form 3310.4 is used to 

report multiple sale or other disposition 

of two or more pistols, revolvers, or any 

combination of pistols or revolvers to an 

unlicensed person, whether it occurs 

one time or within five consecutive 

business days. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: An estimated 82,011 

respondents will complete this form 

approximately 6.33365 times annually, 

and it will take each respondent 

approximately 15 minutes to complete 

their responses. 

6. An estimate of the total public 

burden (in hours) associated with the 

collection: The estimated annual public 

burden associated with this collection is 

129,857 hours, which is equal to 82,011 

(# of respondents) * 6.33365 (# of 

responses per respondent) * .25 (15 

mins). 

7. An Explanation of the Change in 

Estimates: The increase in total 

respondents, responses, and burden 

hours, by 4,106, 63,495, and 15,873 

hours respectively, is due to the revision 

of agency estimates, and a general 

increase in the number of respondents 

since the last renewal in 2018. 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 3E.405A, 

Washington, DC 20530. 

Dated: June 21, 2021. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2021–13419 Filed 6–23–21; 8:45 am] 

BILLING CODE 4410–FY–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–857] 

Bulk Manufacturer of Controlled 

Substances Application: Cambrex 

Charles City 

AGENCY: Drug Enforcement 

Administration, Justice. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices 33359 

ACTION: Notice of application. 

SUMMARY: Cambrex Charles City has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 23, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 23, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on May 6, 2021, Cambrex 

Charles City, 1205 11th Street, Charles 

City, Iowa 50616–3466, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid ............................. 2010 I 

Tetrahydrocannabinols ... 7370 I 

Amphetamine .................. 1100 II 

Lisdexamfetamine ........... 1205 II 

Methylphenidate ............. 1724 II 

ANPP (4-Anilino-Nphenethyl-4-piperidine) 8333 II 

Phenylacetone ................ 8501 II 

Codeine .......................... 9050 II 

Oxycodone ...................... 9143 II 

Hydromorphone .............. 9150 II 

Hydrocodone .................. 9193 II 

Methadone ...................... 9250 II 

Morphine ......................... 9300 II 

Oripavine ........................ 9330 II 

Thebaine ......................... 9333 II 

Opium extracts ............... 9610 II 

Opium fluid extract ......... 9620 II 

Opium tincture ................ 9630 II 

Opium, powdered ........... 9639 II 

Oxymorphone ................. 9652 II 

Noroxymorphone ............ 9668 II 

Fentanyl .......................... 9801 II 

The company plans to manufacture 

the above-listed controlled substances 

in bulk for conversion to other 

controlled substances and sales to its 

customers for dosage form development, 

clinical trials and use in stability 

qualification studies. In reference to 

drug code 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture this drug as 

synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–13252 Filed 6–23–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–858] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: Annac 

Medical Center LC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefor, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 23, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW 8701 

Morrissette Drive, Springfield, Virginia 

22152. To ensure proper handling of 

comments, please reference Docket 

No—DEA–858 in all correspondence, 

including attachments. 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

file written comments on or objections 

of the requested registration, as 

provided in this notice. This notice does 

not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(APIs) for product development and 

distribution to DEA registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 

applicable laws, treaties, and 

regulations and to ensure adequate 

safeguards against diversion are in 

place. 

As this applicant has applied to 

become registered as a bulk 

manufacturer of marihuana, the 

application will be evaluated under the 

criteria of 21 U.S.C. 823(a). In addition 

to seeking to produce marihuana 

extract, this applicant is separately 

seeking to cultivate marihuana. See 

Notice of Application, Bulk 

Manufacturers of Marihuana, 84 FR 

44920, 44922 (Aug. 27, 2019). DEA will 

conduct this evaluation in the manner 

described in the rule published at 85 FR 

82333 on December 18, 2020, and 

reflected in DEA regulations at 21 CFR 

part 1318. 

In accordance with 21 CFR 

1301.33(a), DEA is providing notice that 

on April 14, 2021, Annac Medical 

Center, LC, 5172 West Patrick Lane, 

Suite 100, Las Vegas, Nevada 89117– 

8911, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substances: 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols ... 7370 I 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–13249 Filed 6–23–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Oil 

Pollution Act 

On June 17, 2021, the Department of 

Justice lodged a proposed Consent 

Decree with the United States District 

Court for the Western District of 

Louisiana in the lawsuit entitled United 

States of America and Louisiana v. 

CITGO Petroleum Corp., Civil Action 

No. 2:21–cv–1705. The United States is 


khammond on DSKJM1Z7X2PROD with NOTICES

I I